Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers

Jhih Ying Chi, Yu Wei Hsiao, Chien Feng Li, Yu Chih Lo, Zu Yau Lin, Jhen Yi Hong, Yang Ming Liu, Xiu Han, Shao Ming Wang, Ben Kuen Chen, Kelvin K. Tsai, Ju Ming Wang

研究成果: Article同行評審

32 引文 斯高帕斯(Scopus)

摘要

The tumor microenvironment has been suggested to participate in tumorigenesis, but the nature of the communication between cancer cells and the microenvironment, especially in response to anticancer drugs, remains obscure. We determined that activation of the CCAAT/enhancer binding protein delta (CEBPD) response to Cisplatin and 5-Fluorouracil in cancer-associated macrophages and fibroblasts contributed to the metastasis, invasion, acquired chemoresistance and stemness of cancer cells by in vitro and in vivo assays. Specifically, reporter and in vivo DNA binding assays were used to determine that Pentraxin 3 (PTX3) is a CEBPD responsive gene and serves a protumor role upon anticancer drug treatment. Finally, a PTX3 peptide inhibitor RI37 was developed and assessed the antitumor effects by in vivo assays. RI37 could function as a promising inhibitor for preventing cancer progression and the metastasis, invasion and progression of drug-resistant cancers. The identification of PTX3 provided a new insight in the interaction between host and tumor and the RI37 peptide showed a great opportunity to largely reduce the risk of invasion and metastasis of cancer and drug-resistant cancers.

原文English
頁(從 - 到)23987-24001
頁數15
期刊Oncotarget
6
發行號27
DOIs
出版狀態Published - 2015

All Science Journal Classification (ASJC) codes

  • 腫瘤科

指紋

深入研究「Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers」主題。共同形成了獨特的指紋。

引用此